A Randomized Trial of Rosuvastatin in Elective Angioplasty to Prevent Contrast-induced Nephropathy (CLEAR-CIN).

NCT02737319 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

493

Enrollment

OTHER

Sponsor class

Conditions

Nephropathy

Interventions

DRUG: Rosuvastatin

Sponsor

University of Sao Paulo

Collaborators

[object Object]